Swiss National Bank’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-199,600
Closed -$643K 2751
2022
Q1
$643K Buy
199,600
+16,400
+9% +$55.4K ﹤0.01% 2541
2021
Q4
$788K Hold
183,200
﹤0.01% 2551
2021
Q3
$1.09M Hold
183,200
﹤0.01% 2396
2021
Q2
$1.52M Sell
183,200
-5,500
-3% -$44.7K ﹤0.01% 2272
2021
Q1
$1.62M Hold
188,700
﹤0.01% 2131
2020
Q4
$2.29M Buy
188,700
+8,200
+5% +$113K ﹤0.01% 1821
2020
Q3
$2.93M Buy
180,500
+10,300
+6% +$169K ﹤0.01% 1514
2020
Q2
$2.56M Buy
+170,200
New +$2.3M ﹤0.01% 1571

Other funds holding CGEN

Swiss National Bank's CGEN Position: Q2 2022 in Review

Swiss National Bank sold out of Compugen (CGEN) in Q2 2022, closing a stake of 199,600 shares — an estimated $643K sold.

Swiss National Bank first reported a position in CGEN in Q2 2020 and held it in 8 quarters. The position peaked at $2.93M in Q3 2020. 89 funds tracked by Wall St. Rank hold CGEN as of Q2 2022.

  • Swiss National Bank reported no remaining Compugen position as of Q2 2022 after selling out during the quarter.
  • Swiss National Bank sold 199,600 Compugen shares in Q2 2022, an estimated $643K.
  • Swiss National Bank first reported a position in Compugen in Q2 2020 and held it in 8 quarters.
  • Swiss National Bank's Compugen position peaked at $2.93M in Q3 2020.
  • 89 funds tracked by Wall St. Rank held Compugen as of Q2 2022.

Based on Swiss National Bank's 13F filing for Q2 2022, filed 9 Aug 2022.